References
Humphries SE, Cranston T, Allen M, Middleton-Price H, Fernandes MC, Senior V, Hawe E, Iverson A, Wray R, Crook MA, Wierzbicki AS (2005) Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk, and utility in relative tracing. J Mol Med DOI 10.1007/s00109-005-0019-z
Gotto AM Jr (2004) Targeting high-risk young patients for statin therapy. JAMA 292(3):377–378 (Jul 21)
Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Buller HR, Sijbrands EJ, Kastelein JJ (2004) Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292(3):331–337 (Jul 21)
Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP (2001) Review of first 5 years of screening for familial hypercholesterolemia in the Netherlands. Lancet 357:165–168
Baron H, Fung S, Aydin A, Bahring S, Luft FC, Schuster H (1996) Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia. Nat Biotechnol 14:1279–1282
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luft, F.C. Genetic mutation screening for the low-density lipoprotein receptor. J Mol Med 84, 183–184 (2006). https://doi.org/10.1007/s00109-006-0038-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-006-0038-4